Global NSAID Ophthalmic Drugs Market Growth 2026-2032
The global NSAID Ophthalmic Drugs market size is predicted to grow from US$ 1189 million in 2025 to US$ 2343 million in 2032; it is expected to grow at a CAGR of 10.4% from 2026 to 2032.
Non-steroidal anti-inflammatory drugs have been widely used in ophthalmology clinically due to the lack of adverse reactions such as increased intraocular pressure, secondary infection and cataracts caused by glucocorticoids
United States market for NSAID Ophthalmic Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for NSAID Ophthalmic Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for NSAID Ophthalmic Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key NSAID Ophthalmic Drugs players cover AbbVie, Bausch Health, Bayer, Dossa Pharmaceuticals, GlaxoSmithKline, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “NSAID Ophthalmic Drugs Industry Forecast” looks at past sales and reviews total world NSAID Ophthalmic Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected NSAID Ophthalmic Drugs sales for 2026 through 2032. With NSAID Ophthalmic Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world NSAID Ophthalmic Drugs industry.
This Insight Report provides a comprehensive analysis of the global NSAID Ophthalmic Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on NSAID Ophthalmic Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global NSAID Ophthalmic Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for NSAID Ophthalmic Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global NSAID Ophthalmic Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of NSAID Ophthalmic Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Non-steroidal anti-inflammatory drugs have been widely used in ophthalmology clinically due to the lack of adverse reactions such as increased intraocular pressure, secondary infection and cataracts caused by glucocorticoids
United States market for NSAID Ophthalmic Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for NSAID Ophthalmic Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for NSAID Ophthalmic Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key NSAID Ophthalmic Drugs players cover AbbVie, Bausch Health, Bayer, Dossa Pharmaceuticals, GlaxoSmithKline, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “NSAID Ophthalmic Drugs Industry Forecast” looks at past sales and reviews total world NSAID Ophthalmic Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected NSAID Ophthalmic Drugs sales for 2026 through 2032. With NSAID Ophthalmic Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world NSAID Ophthalmic Drugs industry.
This Insight Report provides a comprehensive analysis of the global NSAID Ophthalmic Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on NSAID Ophthalmic Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global NSAID Ophthalmic Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for NSAID Ophthalmic Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global NSAID Ophthalmic Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of NSAID Ophthalmic Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Pranoprofen Eye Drops
- Diclofenac Sodium Eye Drops
- Bromfenac Sodium Eye Drops
- Other
- Hospital
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AbbVie
- Bausch Health
- Bayer
- Dossa Pharmaceuticals
- GlaxoSmithKline
- Janssen Pharmaceuticals
- Novartis
- Pfizer
- Sun Pharmaceutical Industries
- Senju Pharmaceutical
- Sichuan Heyi Pharmaceutical
- Shandong Haishan Pharmaceutical
- Guangdong Zhongsheng Pharmaceutical
- Hangzhou Minsheng Pharmaceutical
- Cisen Pharmaceutical
- What is the 10-year outlook for the global NSAID Ophthalmic Drugs market?
- What factors are driving NSAID Ophthalmic Drugs market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do NSAID Ophthalmic Drugs market opportunities vary by end market size?
- How does NSAID Ophthalmic Drugs break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global NSAID Ophthalmic Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for NSAID Ophthalmic Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for NSAID Ophthalmic Drugs by Country/Region, 2021, 2025 & 2032
2.2 NSAID Ophthalmic Drugs Segment by Type
2.2.1 Pranoprofen Eye Drops
2.2.2 Diclofenac Sodium Eye Drops
2.2.3 Bromfenac Sodium Eye Drops
2.2.4 Other
2.2.5 NSAID Ophthalmic Drugs Sales by Type
2.2.5.1 Global NSAID Ophthalmic Drugs Sales Market Share by Type (2021-2026)
2.2.5.2 Global NSAID Ophthalmic Drugs Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global NSAID Ophthalmic Drugs Sale Price by Type (2021-2026)
2.3 NSAID Ophthalmic Drugs Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Other
2.3.4 NSAID Ophthalmic Drugs Sales by Application
2.3.4.1 Global NSAID Ophthalmic Drugs Sale Market Share by Application (2021-2026)
2.3.4.2 Global NSAID Ophthalmic Drugs Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global NSAID Ophthalmic Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global NSAID Ophthalmic Drugs Breakdown Data by Company
3.1.1 Global NSAID Ophthalmic Drugs Annual Sales by Company (2021-2026)
3.1.2 Global NSAID Ophthalmic Drugs Sales Market Share by Company (2021-2026)
3.2 Global NSAID Ophthalmic Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global NSAID Ophthalmic Drugs Revenue by Company (2021-2026)
3.2.2 Global NSAID Ophthalmic Drugs Revenue Market Share by Company (2021-2026)
3.3 Global NSAID Ophthalmic Drugs Sale Price by Company
3.4 Key Manufacturers NSAID Ophthalmic Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers NSAID Ophthalmic Drugs Product Location Distribution
3.4.2 Players NSAID Ophthalmic Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NSAID OPHTHALMIC DRUGS BY GEOGRAPHIC REGION
4.1 World Historic NSAID Ophthalmic Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global NSAID Ophthalmic Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global NSAID Ophthalmic Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic NSAID Ophthalmic Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global NSAID Ophthalmic Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global NSAID Ophthalmic Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas NSAID Ophthalmic Drugs Sales Growth
4.4 APAC NSAID Ophthalmic Drugs Sales Growth
4.5 Europe NSAID Ophthalmic Drugs Sales Growth
4.6 Middle East & Africa NSAID Ophthalmic Drugs Sales Growth
5 AMERICAS
5.1 Americas NSAID Ophthalmic Drugs Sales by Country
5.1.1 Americas NSAID Ophthalmic Drugs Sales by Country (2021-2026)
5.1.2 Americas NSAID Ophthalmic Drugs Revenue by Country (2021-2026)
5.2 Americas NSAID Ophthalmic Drugs Sales by Type (2021-2026)
5.3 Americas NSAID Ophthalmic Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC NSAID Ophthalmic Drugs Sales by Region
6.1.1 APAC NSAID Ophthalmic Drugs Sales by Region (2021-2026)
6.1.2 APAC NSAID Ophthalmic Drugs Revenue by Region (2021-2026)
6.2 APAC NSAID Ophthalmic Drugs Sales by Type (2021-2026)
6.3 APAC NSAID Ophthalmic Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe NSAID Ophthalmic Drugs by Country
7.1.1 Europe NSAID Ophthalmic Drugs Sales by Country (2021-2026)
7.1.2 Europe NSAID Ophthalmic Drugs Revenue by Country (2021-2026)
7.2 Europe NSAID Ophthalmic Drugs Sales by Type (2021-2026)
7.3 Europe NSAID Ophthalmic Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa NSAID Ophthalmic Drugs by Country
8.1.1 Middle East & Africa NSAID Ophthalmic Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa NSAID Ophthalmic Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa NSAID Ophthalmic Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa NSAID Ophthalmic Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of NSAID Ophthalmic Drugs
10.3 Manufacturing Process Analysis of NSAID Ophthalmic Drugs
10.4 Industry Chain Structure of NSAID Ophthalmic Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 NSAID Ophthalmic Drugs Distributors
11.3 NSAID Ophthalmic Drugs Customer
12 WORLD FORECAST REVIEW FOR NSAID OPHTHALMIC DRUGS BY GEOGRAPHIC REGION
12.1 Global NSAID Ophthalmic Drugs Market Size Forecast by Region
12.1.1 Global NSAID Ophthalmic Drugs Forecast by Region (2027-2032)
12.1.2 Global NSAID Ophthalmic Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global NSAID Ophthalmic Drugs Forecast by Type (2027-2032)
12.7 Global NSAID Ophthalmic Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 AbbVie
13.1.1 AbbVie Company Information
13.1.2 AbbVie NSAID Ophthalmic Drugs Product Portfolios and Specifications
13.1.3 AbbVie NSAID Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 AbbVie Main Business Overview
13.1.5 AbbVie Latest Developments
13.2 Bausch Health
13.2.1 Bausch Health Company Information
13.2.2 Bausch Health NSAID Ophthalmic Drugs Product Portfolios and Specifications
13.2.3 Bausch Health NSAID Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Bausch Health Main Business Overview
13.2.5 Bausch Health Latest Developments
13.3 Bayer
13.3.1 Bayer Company Information
13.3.2 Bayer NSAID Ophthalmic Drugs Product Portfolios and Specifications
13.3.3 Bayer NSAID Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Bayer Main Business Overview
13.3.5 Bayer Latest Developments
13.4 Dossa Pharmaceuticals
13.4.1 Dossa Pharmaceuticals Company Information
13.4.2 Dossa Pharmaceuticals NSAID Ophthalmic Drugs Product Portfolios and Specifications
13.4.3 Dossa Pharmaceuticals NSAID Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Dossa Pharmaceuticals Main Business Overview
13.4.5 Dossa Pharmaceuticals Latest Developments
13.5 GlaxoSmithKline
13.5.1 GlaxoSmithKline Company Information
13.5.2 GlaxoSmithKline NSAID Ophthalmic Drugs Product Portfolios and Specifications
13.5.3 GlaxoSmithKline NSAID Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 GlaxoSmithKline Main Business Overview
13.5.5 GlaxoSmithKline Latest Developments
13.6 Janssen Pharmaceuticals
13.6.1 Janssen Pharmaceuticals Company Information
13.6.2 Janssen Pharmaceuticals NSAID Ophthalmic Drugs Product Portfolios and Specifications
13.6.3 Janssen Pharmaceuticals NSAID Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Janssen Pharmaceuticals Main Business Overview
13.6.5 Janssen Pharmaceuticals Latest Developments
13.7 Novartis
13.7.1 Novartis Company Information
13.7.2 Novartis NSAID Ophthalmic Drugs Product Portfolios and Specifications
13.7.3 Novartis NSAID Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Novartis Main Business Overview
13.7.5 Novartis Latest Developments
13.8 Pfizer
13.8.1 Pfizer Company Information
13.8.2 Pfizer NSAID Ophthalmic Drugs Product Portfolios and Specifications
13.8.3 Pfizer NSAID Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Pfizer Main Business Overview
13.8.5 Pfizer Latest Developments
13.9 Sun Pharmaceutical Industries
13.9.1 Sun Pharmaceutical Industries Company Information
13.9.2 Sun Pharmaceutical Industries NSAID Ophthalmic Drugs Product Portfolios and Specifications
13.9.3 Sun Pharmaceutical Industries NSAID Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Sun Pharmaceutical Industries Main Business Overview
13.9.5 Sun Pharmaceutical Industries Latest Developments
13.10 Senju Pharmaceutical
13.10.1 Senju Pharmaceutical Company Information
13.10.2 Senju Pharmaceutical NSAID Ophthalmic Drugs Product Portfolios and Specifications
13.10.3 Senju Pharmaceutical NSAID Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Senju Pharmaceutical Main Business Overview
13.10.5 Senju Pharmaceutical Latest Developments
13.11 Sichuan Heyi Pharmaceutical
13.11.1 Sichuan Heyi Pharmaceutical Company Information
13.11.2 Sichuan Heyi Pharmaceutical NSAID Ophthalmic Drugs Product Portfolios and Specifications
13.11.3 Sichuan Heyi Pharmaceutical NSAID Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Sichuan Heyi Pharmaceutical Main Business Overview
13.11.5 Sichuan Heyi Pharmaceutical Latest Developments
13.12 Shandong Haishan Pharmaceutical
13.12.1 Shandong Haishan Pharmaceutical Company Information
13.12.2 Shandong Haishan Pharmaceutical NSAID Ophthalmic Drugs Product Portfolios and Specifications
13.12.3 Shandong Haishan Pharmaceutical NSAID Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Shandong Haishan Pharmaceutical Main Business Overview
13.12.5 Shandong Haishan Pharmaceutical Latest Developments
13.13 Guangdong Zhongsheng Pharmaceutical
13.13.1 Guangdong Zhongsheng Pharmaceutical Company Information
13.13.2 Guangdong Zhongsheng Pharmaceutical NSAID Ophthalmic Drugs Product Portfolios and Specifications
13.13.3 Guangdong Zhongsheng Pharmaceutical NSAID Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Guangdong Zhongsheng Pharmaceutical Main Business Overview
13.13.5 Guangdong Zhongsheng Pharmaceutical Latest Developments
13.14 Hangzhou Minsheng Pharmaceutical
13.14.1 Hangzhou Minsheng Pharmaceutical Company Information
13.14.2 Hangzhou Minsheng Pharmaceutical NSAID Ophthalmic Drugs Product Portfolios and Specifications
13.14.3 Hangzhou Minsheng Pharmaceutical NSAID Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Hangzhou Minsheng Pharmaceutical Main Business Overview
13.14.5 Hangzhou Minsheng Pharmaceutical Latest Developments
13.15 Cisen Pharmaceutical
13.15.1 Cisen Pharmaceutical Company Information
13.15.2 Cisen Pharmaceutical NSAID Ophthalmic Drugs Product Portfolios and Specifications
13.15.3 Cisen Pharmaceutical NSAID Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Cisen Pharmaceutical Main Business Overview
13.15.5 Cisen Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global NSAID Ophthalmic Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for NSAID Ophthalmic Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for NSAID Ophthalmic Drugs by Country/Region, 2021, 2025 & 2032
2.2 NSAID Ophthalmic Drugs Segment by Type
2.2.1 Pranoprofen Eye Drops
2.2.2 Diclofenac Sodium Eye Drops
2.2.3 Bromfenac Sodium Eye Drops
2.2.4 Other
2.2.5 NSAID Ophthalmic Drugs Sales by Type
2.2.5.1 Global NSAID Ophthalmic Drugs Sales Market Share by Type (2021-2026)
2.2.5.2 Global NSAID Ophthalmic Drugs Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global NSAID Ophthalmic Drugs Sale Price by Type (2021-2026)
2.3 NSAID Ophthalmic Drugs Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Other
2.3.4 NSAID Ophthalmic Drugs Sales by Application
2.3.4.1 Global NSAID Ophthalmic Drugs Sale Market Share by Application (2021-2026)
2.3.4.2 Global NSAID Ophthalmic Drugs Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global NSAID Ophthalmic Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global NSAID Ophthalmic Drugs Breakdown Data by Company
3.1.1 Global NSAID Ophthalmic Drugs Annual Sales by Company (2021-2026)
3.1.2 Global NSAID Ophthalmic Drugs Sales Market Share by Company (2021-2026)
3.2 Global NSAID Ophthalmic Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global NSAID Ophthalmic Drugs Revenue by Company (2021-2026)
3.2.2 Global NSAID Ophthalmic Drugs Revenue Market Share by Company (2021-2026)
3.3 Global NSAID Ophthalmic Drugs Sale Price by Company
3.4 Key Manufacturers NSAID Ophthalmic Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers NSAID Ophthalmic Drugs Product Location Distribution
3.4.2 Players NSAID Ophthalmic Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NSAID OPHTHALMIC DRUGS BY GEOGRAPHIC REGION
4.1 World Historic NSAID Ophthalmic Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global NSAID Ophthalmic Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global NSAID Ophthalmic Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic NSAID Ophthalmic Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global NSAID Ophthalmic Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global NSAID Ophthalmic Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas NSAID Ophthalmic Drugs Sales Growth
4.4 APAC NSAID Ophthalmic Drugs Sales Growth
4.5 Europe NSAID Ophthalmic Drugs Sales Growth
4.6 Middle East & Africa NSAID Ophthalmic Drugs Sales Growth
5 AMERICAS
5.1 Americas NSAID Ophthalmic Drugs Sales by Country
5.1.1 Americas NSAID Ophthalmic Drugs Sales by Country (2021-2026)
5.1.2 Americas NSAID Ophthalmic Drugs Revenue by Country (2021-2026)
5.2 Americas NSAID Ophthalmic Drugs Sales by Type (2021-2026)
5.3 Americas NSAID Ophthalmic Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC NSAID Ophthalmic Drugs Sales by Region
6.1.1 APAC NSAID Ophthalmic Drugs Sales by Region (2021-2026)
6.1.2 APAC NSAID Ophthalmic Drugs Revenue by Region (2021-2026)
6.2 APAC NSAID Ophthalmic Drugs Sales by Type (2021-2026)
6.3 APAC NSAID Ophthalmic Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe NSAID Ophthalmic Drugs by Country
7.1.1 Europe NSAID Ophthalmic Drugs Sales by Country (2021-2026)
7.1.2 Europe NSAID Ophthalmic Drugs Revenue by Country (2021-2026)
7.2 Europe NSAID Ophthalmic Drugs Sales by Type (2021-2026)
7.3 Europe NSAID Ophthalmic Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa NSAID Ophthalmic Drugs by Country
8.1.1 Middle East & Africa NSAID Ophthalmic Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa NSAID Ophthalmic Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa NSAID Ophthalmic Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa NSAID Ophthalmic Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of NSAID Ophthalmic Drugs
10.3 Manufacturing Process Analysis of NSAID Ophthalmic Drugs
10.4 Industry Chain Structure of NSAID Ophthalmic Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 NSAID Ophthalmic Drugs Distributors
11.3 NSAID Ophthalmic Drugs Customer
12 WORLD FORECAST REVIEW FOR NSAID OPHTHALMIC DRUGS BY GEOGRAPHIC REGION
12.1 Global NSAID Ophthalmic Drugs Market Size Forecast by Region
12.1.1 Global NSAID Ophthalmic Drugs Forecast by Region (2027-2032)
12.1.2 Global NSAID Ophthalmic Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global NSAID Ophthalmic Drugs Forecast by Type (2027-2032)
12.7 Global NSAID Ophthalmic Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 AbbVie
13.1.1 AbbVie Company Information
13.1.2 AbbVie NSAID Ophthalmic Drugs Product Portfolios and Specifications
13.1.3 AbbVie NSAID Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 AbbVie Main Business Overview
13.1.5 AbbVie Latest Developments
13.2 Bausch Health
13.2.1 Bausch Health Company Information
13.2.2 Bausch Health NSAID Ophthalmic Drugs Product Portfolios and Specifications
13.2.3 Bausch Health NSAID Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Bausch Health Main Business Overview
13.2.5 Bausch Health Latest Developments
13.3 Bayer
13.3.1 Bayer Company Information
13.3.2 Bayer NSAID Ophthalmic Drugs Product Portfolios and Specifications
13.3.3 Bayer NSAID Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Bayer Main Business Overview
13.3.5 Bayer Latest Developments
13.4 Dossa Pharmaceuticals
13.4.1 Dossa Pharmaceuticals Company Information
13.4.2 Dossa Pharmaceuticals NSAID Ophthalmic Drugs Product Portfolios and Specifications
13.4.3 Dossa Pharmaceuticals NSAID Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Dossa Pharmaceuticals Main Business Overview
13.4.5 Dossa Pharmaceuticals Latest Developments
13.5 GlaxoSmithKline
13.5.1 GlaxoSmithKline Company Information
13.5.2 GlaxoSmithKline NSAID Ophthalmic Drugs Product Portfolios and Specifications
13.5.3 GlaxoSmithKline NSAID Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 GlaxoSmithKline Main Business Overview
13.5.5 GlaxoSmithKline Latest Developments
13.6 Janssen Pharmaceuticals
13.6.1 Janssen Pharmaceuticals Company Information
13.6.2 Janssen Pharmaceuticals NSAID Ophthalmic Drugs Product Portfolios and Specifications
13.6.3 Janssen Pharmaceuticals NSAID Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Janssen Pharmaceuticals Main Business Overview
13.6.5 Janssen Pharmaceuticals Latest Developments
13.7 Novartis
13.7.1 Novartis Company Information
13.7.2 Novartis NSAID Ophthalmic Drugs Product Portfolios and Specifications
13.7.3 Novartis NSAID Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Novartis Main Business Overview
13.7.5 Novartis Latest Developments
13.8 Pfizer
13.8.1 Pfizer Company Information
13.8.2 Pfizer NSAID Ophthalmic Drugs Product Portfolios and Specifications
13.8.3 Pfizer NSAID Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Pfizer Main Business Overview
13.8.5 Pfizer Latest Developments
13.9 Sun Pharmaceutical Industries
13.9.1 Sun Pharmaceutical Industries Company Information
13.9.2 Sun Pharmaceutical Industries NSAID Ophthalmic Drugs Product Portfolios and Specifications
13.9.3 Sun Pharmaceutical Industries NSAID Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Sun Pharmaceutical Industries Main Business Overview
13.9.5 Sun Pharmaceutical Industries Latest Developments
13.10 Senju Pharmaceutical
13.10.1 Senju Pharmaceutical Company Information
13.10.2 Senju Pharmaceutical NSAID Ophthalmic Drugs Product Portfolios and Specifications
13.10.3 Senju Pharmaceutical NSAID Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Senju Pharmaceutical Main Business Overview
13.10.5 Senju Pharmaceutical Latest Developments
13.11 Sichuan Heyi Pharmaceutical
13.11.1 Sichuan Heyi Pharmaceutical Company Information
13.11.2 Sichuan Heyi Pharmaceutical NSAID Ophthalmic Drugs Product Portfolios and Specifications
13.11.3 Sichuan Heyi Pharmaceutical NSAID Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Sichuan Heyi Pharmaceutical Main Business Overview
13.11.5 Sichuan Heyi Pharmaceutical Latest Developments
13.12 Shandong Haishan Pharmaceutical
13.12.1 Shandong Haishan Pharmaceutical Company Information
13.12.2 Shandong Haishan Pharmaceutical NSAID Ophthalmic Drugs Product Portfolios and Specifications
13.12.3 Shandong Haishan Pharmaceutical NSAID Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Shandong Haishan Pharmaceutical Main Business Overview
13.12.5 Shandong Haishan Pharmaceutical Latest Developments
13.13 Guangdong Zhongsheng Pharmaceutical
13.13.1 Guangdong Zhongsheng Pharmaceutical Company Information
13.13.2 Guangdong Zhongsheng Pharmaceutical NSAID Ophthalmic Drugs Product Portfolios and Specifications
13.13.3 Guangdong Zhongsheng Pharmaceutical NSAID Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Guangdong Zhongsheng Pharmaceutical Main Business Overview
13.13.5 Guangdong Zhongsheng Pharmaceutical Latest Developments
13.14 Hangzhou Minsheng Pharmaceutical
13.14.1 Hangzhou Minsheng Pharmaceutical Company Information
13.14.2 Hangzhou Minsheng Pharmaceutical NSAID Ophthalmic Drugs Product Portfolios and Specifications
13.14.3 Hangzhou Minsheng Pharmaceutical NSAID Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Hangzhou Minsheng Pharmaceutical Main Business Overview
13.14.5 Hangzhou Minsheng Pharmaceutical Latest Developments
13.15 Cisen Pharmaceutical
13.15.1 Cisen Pharmaceutical Company Information
13.15.2 Cisen Pharmaceutical NSAID Ophthalmic Drugs Product Portfolios and Specifications
13.15.3 Cisen Pharmaceutical NSAID Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Cisen Pharmaceutical Main Business Overview
13.15.5 Cisen Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. NSAID Ophthalmic Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. NSAID Ophthalmic Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Pranoprofen Eye Drops
Table 4. Major Players of Diclofenac Sodium Eye Drops
Table 5. Major Players of Bromfenac Sodium Eye Drops
Table 6. Major Players of Other
Table 7. Global NSAID Ophthalmic Drugs Sales by Type (2021-2026) & (K Units)
Table 8. Global NSAID Ophthalmic Drugs Sales Market Share by Type (2021-2026)
Table 9. Global NSAID Ophthalmic Drugs Revenue by Type (2021-2026) & ($ million)
Table 10. Global NSAID Ophthalmic Drugs Revenue Market Share by Type (2021-2026)
Table 11. Global NSAID Ophthalmic Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Global NSAID Ophthalmic Drugs Sale by Application (2021-2026) & (K Units)
Table 13. Global NSAID Ophthalmic Drugs Sale Market Share by Application (2021-2026)
Table 14. Global NSAID Ophthalmic Drugs Revenue by Application (2021-2026) & ($ million)
Table 15. Global NSAID Ophthalmic Drugs Revenue Market Share by Application (2021-2026)
Table 16. Global NSAID Ophthalmic Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 17. Global NSAID Ophthalmic Drugs Sales by Company (2021-2026) & (K Units)
Table 18. Global NSAID Ophthalmic Drugs Sales Market Share by Company (2021-2026)
Table 19. Global NSAID Ophthalmic Drugs Revenue by Company (2021-2026) & ($ millions)
Table 20. Global NSAID Ophthalmic Drugs Revenue Market Share by Company (2021-2026)
Table 21. Global NSAID Ophthalmic Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 22. Key Manufacturers NSAID Ophthalmic Drugs Producing Area Distribution and Sales Area
Table 23. Players NSAID Ophthalmic Drugs Products Offered
Table 24. NSAID Ophthalmic Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global NSAID Ophthalmic Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 28. Global NSAID Ophthalmic Drugs Sales Market Share Geographic Region (2021-2026)
Table 29. Global NSAID Ophthalmic Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global NSAID Ophthalmic Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global NSAID Ophthalmic Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 32. Global NSAID Ophthalmic Drugs Sales Market Share by Country/Region (2021-2026)
Table 33. Global NSAID Ophthalmic Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global NSAID Ophthalmic Drugs Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas NSAID Ophthalmic Drugs Sales by Country (2021-2026) & (K Units)
Table 36. Americas NSAID Ophthalmic Drugs Sales Market Share by Country (2021-2026)
Table 37. Americas NSAID Ophthalmic Drugs Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas NSAID Ophthalmic Drugs Sales by Type (2021-2026) & (K Units)
Table 39. Americas NSAID Ophthalmic Drugs Sales by Application (2021-2026) & (K Units)
Table 40. APAC NSAID Ophthalmic Drugs Sales by Region (2021-2026) & (K Units)
Table 41. APAC NSAID Ophthalmic Drugs Sales Market Share by Region (2021-2026)
Table 42. APAC NSAID Ophthalmic Drugs Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC NSAID Ophthalmic Drugs Sales by Type (2021-2026) & (K Units)
Table 44. APAC NSAID Ophthalmic Drugs Sales by Application (2021-2026) & (K Units)
Table 45. Europe NSAID Ophthalmic Drugs Sales by Country (2021-2026) & (K Units)
Table 46. Europe NSAID Ophthalmic Drugs Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe NSAID Ophthalmic Drugs Sales by Type (2021-2026) & (K Units)
Table 48. Europe NSAID Ophthalmic Drugs Sales by Application (2021-2026) & (K Units)
Table 49. Middle East & Africa NSAID Ophthalmic Drugs Sales by Country (2021-2026) & (K Units)
Table 50. Middle East & Africa NSAID Ophthalmic Drugs Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa NSAID Ophthalmic Drugs Sales by Type (2021-2026) & (K Units)
Table 52. Middle East & Africa NSAID Ophthalmic Drugs Sales by Application (2021-2026) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of NSAID Ophthalmic Drugs
Table 54. Key Market Challenges & Risks of NSAID Ophthalmic Drugs
Table 55. Key Industry Trends of NSAID Ophthalmic Drugs
Table 56. NSAID Ophthalmic Drugs Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. NSAID Ophthalmic Drugs Distributors List
Table 59. NSAID Ophthalmic Drugs Customer List
Table 60. Global NSAID Ophthalmic Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 61. Global NSAID Ophthalmic Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas NSAID Ophthalmic Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 63. Americas NSAID Ophthalmic Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC NSAID Ophthalmic Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 65. APAC NSAID Ophthalmic Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe NSAID Ophthalmic Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Europe NSAID Ophthalmic Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa NSAID Ophthalmic Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Middle East & Africa NSAID Ophthalmic Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global NSAID Ophthalmic Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 71. Global NSAID Ophthalmic Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global NSAID Ophthalmic Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 73. Global NSAID Ophthalmic Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. AbbVie Basic Information, NSAID Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 75. AbbVie NSAID Ophthalmic Drugs Product Portfolios and Specifications
Table 76. AbbVie NSAID Ophthalmic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 77. AbbVie Main Business
Table 78. AbbVie Latest Developments
Table 79. Bausch Health Basic Information, NSAID Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 80. Bausch Health NSAID Ophthalmic Drugs Product Portfolios and Specifications
Table 81. Bausch Health NSAID Ophthalmic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 82. Bausch Health Main Business
Table 83. Bausch Health Latest Developments
Table 84. Bayer Basic Information, NSAID Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 85. Bayer NSAID Ophthalmic Drugs Product Portfolios and Specifications
Table 86. Bayer NSAID Ophthalmic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 87. Bayer Main Business
Table 88. Bayer Latest Developments
Table 89. Dossa Pharmaceuticals Basic Information, NSAID Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 90. Dossa Pharmaceuticals NSAID Ophthalmic Drugs Product Portfolios and Specifications
Table 91. Dossa Pharmaceuticals NSAID Ophthalmic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. Dossa Pharmaceuticals Main Business
Table 93. Dossa Pharmaceuticals Latest Developments
Table 94. GlaxoSmithKline Basic Information, NSAID Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. GlaxoSmithKline NSAID Ophthalmic Drugs Product Portfolios and Specifications
Table 96. GlaxoSmithKline NSAID Ophthalmic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. GlaxoSmithKline Main Business
Table 98. GlaxoSmithKline Latest Developments
Table 99. Janssen Pharmaceuticals Basic Information, NSAID Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. Janssen Pharmaceuticals NSAID Ophthalmic Drugs Product Portfolios and Specifications
Table 101. Janssen Pharmaceuticals NSAID Ophthalmic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Janssen Pharmaceuticals Main Business
Table 103. Janssen Pharmaceuticals Latest Developments
Table 104. Novartis Basic Information, NSAID Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. Novartis NSAID Ophthalmic Drugs Product Portfolios and Specifications
Table 106. Novartis NSAID Ophthalmic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Novartis Main Business
Table 108. Novartis Latest Developments
Table 109. Pfizer Basic Information, NSAID Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 110. Pfizer NSAID Ophthalmic Drugs Product Portfolios and Specifications
Table 111. Pfizer NSAID Ophthalmic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Pfizer Main Business
Table 113. Pfizer Latest Developments
Table 114. Sun Pharmaceutical Industries Basic Information, NSAID Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 115. Sun Pharmaceutical Industries NSAID Ophthalmic Drugs Product Portfolios and Specifications
Table 116. Sun Pharmaceutical Industries NSAID Ophthalmic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Sun Pharmaceutical Industries Main Business
Table 118. Sun Pharmaceutical Industries Latest Developments
Table 119. Senju Pharmaceutical Basic Information, NSAID Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 120. Senju Pharmaceutical NSAID Ophthalmic Drugs Product Portfolios and Specifications
Table 121. Senju Pharmaceutical NSAID Ophthalmic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Senju Pharmaceutical Main Business
Table 123. Senju Pharmaceutical Latest Developments
Table 124. Sichuan Heyi Pharmaceutical Basic Information, NSAID Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 125. Sichuan Heyi Pharmaceutical NSAID Ophthalmic Drugs Product Portfolios and Specifications
Table 126. Sichuan Heyi Pharmaceutical NSAID Ophthalmic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Sichuan Heyi Pharmaceutical Main Business
Table 128. Sichuan Heyi Pharmaceutical Latest Developments
Table 129. Shandong Haishan Pharmaceutical Basic Information, NSAID Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 130. Shandong Haishan Pharmaceutical NSAID Ophthalmic Drugs Product Portfolios and Specifications
Table 131. Shandong Haishan Pharmaceutical NSAID Ophthalmic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. Shandong Haishan Pharmaceutical Main Business
Table 133. Shandong Haishan Pharmaceutical Latest Developments
Table 134. Guangdong Zhongsheng Pharmaceutical Basic Information, NSAID Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 135. Guangdong Zhongsheng Pharmaceutical NSAID Ophthalmic Drugs Product Portfolios and Specifications
Table 136. Guangdong Zhongsheng Pharmaceutical NSAID Ophthalmic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. Guangdong Zhongsheng Pharmaceutical Main Business
Table 138. Guangdong Zhongsheng Pharmaceutical Latest Developments
Table 139. Hangzhou Minsheng Pharmaceutical Basic Information, NSAID Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 140. Hangzhou Minsheng Pharmaceutical NSAID Ophthalmic Drugs Product Portfolios and Specifications
Table 141. Hangzhou Minsheng Pharmaceutical NSAID Ophthalmic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. Hangzhou Minsheng Pharmaceutical Main Business
Table 143. Hangzhou Minsheng Pharmaceutical Latest Developments
Table 144. Cisen Pharmaceutical Basic Information, NSAID Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 145. Cisen Pharmaceutical NSAID Ophthalmic Drugs Product Portfolios and Specifications
Table 146. Cisen Pharmaceutical NSAID Ophthalmic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 147. Cisen Pharmaceutical Main Business
Table 148. Cisen Pharmaceutical Latest Developments
Table 1. NSAID Ophthalmic Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. NSAID Ophthalmic Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Pranoprofen Eye Drops
Table 4. Major Players of Diclofenac Sodium Eye Drops
Table 5. Major Players of Bromfenac Sodium Eye Drops
Table 6. Major Players of Other
Table 7. Global NSAID Ophthalmic Drugs Sales by Type (2021-2026) & (K Units)
Table 8. Global NSAID Ophthalmic Drugs Sales Market Share by Type (2021-2026)
Table 9. Global NSAID Ophthalmic Drugs Revenue by Type (2021-2026) & ($ million)
Table 10. Global NSAID Ophthalmic Drugs Revenue Market Share by Type (2021-2026)
Table 11. Global NSAID Ophthalmic Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Global NSAID Ophthalmic Drugs Sale by Application (2021-2026) & (K Units)
Table 13. Global NSAID Ophthalmic Drugs Sale Market Share by Application (2021-2026)
Table 14. Global NSAID Ophthalmic Drugs Revenue by Application (2021-2026) & ($ million)
Table 15. Global NSAID Ophthalmic Drugs Revenue Market Share by Application (2021-2026)
Table 16. Global NSAID Ophthalmic Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 17. Global NSAID Ophthalmic Drugs Sales by Company (2021-2026) & (K Units)
Table 18. Global NSAID Ophthalmic Drugs Sales Market Share by Company (2021-2026)
Table 19. Global NSAID Ophthalmic Drugs Revenue by Company (2021-2026) & ($ millions)
Table 20. Global NSAID Ophthalmic Drugs Revenue Market Share by Company (2021-2026)
Table 21. Global NSAID Ophthalmic Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 22. Key Manufacturers NSAID Ophthalmic Drugs Producing Area Distribution and Sales Area
Table 23. Players NSAID Ophthalmic Drugs Products Offered
Table 24. NSAID Ophthalmic Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global NSAID Ophthalmic Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 28. Global NSAID Ophthalmic Drugs Sales Market Share Geographic Region (2021-2026)
Table 29. Global NSAID Ophthalmic Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global NSAID Ophthalmic Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global NSAID Ophthalmic Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 32. Global NSAID Ophthalmic Drugs Sales Market Share by Country/Region (2021-2026)
Table 33. Global NSAID Ophthalmic Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global NSAID Ophthalmic Drugs Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas NSAID Ophthalmic Drugs Sales by Country (2021-2026) & (K Units)
Table 36. Americas NSAID Ophthalmic Drugs Sales Market Share by Country (2021-2026)
Table 37. Americas NSAID Ophthalmic Drugs Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas NSAID Ophthalmic Drugs Sales by Type (2021-2026) & (K Units)
Table 39. Americas NSAID Ophthalmic Drugs Sales by Application (2021-2026) & (K Units)
Table 40. APAC NSAID Ophthalmic Drugs Sales by Region (2021-2026) & (K Units)
Table 41. APAC NSAID Ophthalmic Drugs Sales Market Share by Region (2021-2026)
Table 42. APAC NSAID Ophthalmic Drugs Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC NSAID Ophthalmic Drugs Sales by Type (2021-2026) & (K Units)
Table 44. APAC NSAID Ophthalmic Drugs Sales by Application (2021-2026) & (K Units)
Table 45. Europe NSAID Ophthalmic Drugs Sales by Country (2021-2026) & (K Units)
Table 46. Europe NSAID Ophthalmic Drugs Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe NSAID Ophthalmic Drugs Sales by Type (2021-2026) & (K Units)
Table 48. Europe NSAID Ophthalmic Drugs Sales by Application (2021-2026) & (K Units)
Table 49. Middle East & Africa NSAID Ophthalmic Drugs Sales by Country (2021-2026) & (K Units)
Table 50. Middle East & Africa NSAID Ophthalmic Drugs Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa NSAID Ophthalmic Drugs Sales by Type (2021-2026) & (K Units)
Table 52. Middle East & Africa NSAID Ophthalmic Drugs Sales by Application (2021-2026) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of NSAID Ophthalmic Drugs
Table 54. Key Market Challenges & Risks of NSAID Ophthalmic Drugs
Table 55. Key Industry Trends of NSAID Ophthalmic Drugs
Table 56. NSAID Ophthalmic Drugs Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. NSAID Ophthalmic Drugs Distributors List
Table 59. NSAID Ophthalmic Drugs Customer List
Table 60. Global NSAID Ophthalmic Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 61. Global NSAID Ophthalmic Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas NSAID Ophthalmic Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 63. Americas NSAID Ophthalmic Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC NSAID Ophthalmic Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 65. APAC NSAID Ophthalmic Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe NSAID Ophthalmic Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Europe NSAID Ophthalmic Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa NSAID Ophthalmic Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Middle East & Africa NSAID Ophthalmic Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global NSAID Ophthalmic Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 71. Global NSAID Ophthalmic Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global NSAID Ophthalmic Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 73. Global NSAID Ophthalmic Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. AbbVie Basic Information, NSAID Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 75. AbbVie NSAID Ophthalmic Drugs Product Portfolios and Specifications
Table 76. AbbVie NSAID Ophthalmic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 77. AbbVie Main Business
Table 78. AbbVie Latest Developments
Table 79. Bausch Health Basic Information, NSAID Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 80. Bausch Health NSAID Ophthalmic Drugs Product Portfolios and Specifications
Table 81. Bausch Health NSAID Ophthalmic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 82. Bausch Health Main Business
Table 83. Bausch Health Latest Developments
Table 84. Bayer Basic Information, NSAID Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 85. Bayer NSAID Ophthalmic Drugs Product Portfolios and Specifications
Table 86. Bayer NSAID Ophthalmic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 87. Bayer Main Business
Table 88. Bayer Latest Developments
Table 89. Dossa Pharmaceuticals Basic Information, NSAID Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 90. Dossa Pharmaceuticals NSAID Ophthalmic Drugs Product Portfolios and Specifications
Table 91. Dossa Pharmaceuticals NSAID Ophthalmic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. Dossa Pharmaceuticals Main Business
Table 93. Dossa Pharmaceuticals Latest Developments
Table 94. GlaxoSmithKline Basic Information, NSAID Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. GlaxoSmithKline NSAID Ophthalmic Drugs Product Portfolios and Specifications
Table 96. GlaxoSmithKline NSAID Ophthalmic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. GlaxoSmithKline Main Business
Table 98. GlaxoSmithKline Latest Developments
Table 99. Janssen Pharmaceuticals Basic Information, NSAID Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. Janssen Pharmaceuticals NSAID Ophthalmic Drugs Product Portfolios and Specifications
Table 101. Janssen Pharmaceuticals NSAID Ophthalmic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Janssen Pharmaceuticals Main Business
Table 103. Janssen Pharmaceuticals Latest Developments
Table 104. Novartis Basic Information, NSAID Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. Novartis NSAID Ophthalmic Drugs Product Portfolios and Specifications
Table 106. Novartis NSAID Ophthalmic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Novartis Main Business
Table 108. Novartis Latest Developments
Table 109. Pfizer Basic Information, NSAID Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 110. Pfizer NSAID Ophthalmic Drugs Product Portfolios and Specifications
Table 111. Pfizer NSAID Ophthalmic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Pfizer Main Business
Table 113. Pfizer Latest Developments
Table 114. Sun Pharmaceutical Industries Basic Information, NSAID Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 115. Sun Pharmaceutical Industries NSAID Ophthalmic Drugs Product Portfolios and Specifications
Table 116. Sun Pharmaceutical Industries NSAID Ophthalmic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Sun Pharmaceutical Industries Main Business
Table 118. Sun Pharmaceutical Industries Latest Developments
Table 119. Senju Pharmaceutical Basic Information, NSAID Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 120. Senju Pharmaceutical NSAID Ophthalmic Drugs Product Portfolios and Specifications
Table 121. Senju Pharmaceutical NSAID Ophthalmic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Senju Pharmaceutical Main Business
Table 123. Senju Pharmaceutical Latest Developments
Table 124. Sichuan Heyi Pharmaceutical Basic Information, NSAID Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 125. Sichuan Heyi Pharmaceutical NSAID Ophthalmic Drugs Product Portfolios and Specifications
Table 126. Sichuan Heyi Pharmaceutical NSAID Ophthalmic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Sichuan Heyi Pharmaceutical Main Business
Table 128. Sichuan Heyi Pharmaceutical Latest Developments
Table 129. Shandong Haishan Pharmaceutical Basic Information, NSAID Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 130. Shandong Haishan Pharmaceutical NSAID Ophthalmic Drugs Product Portfolios and Specifications
Table 131. Shandong Haishan Pharmaceutical NSAID Ophthalmic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. Shandong Haishan Pharmaceutical Main Business
Table 133. Shandong Haishan Pharmaceutical Latest Developments
Table 134. Guangdong Zhongsheng Pharmaceutical Basic Information, NSAID Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 135. Guangdong Zhongsheng Pharmaceutical NSAID Ophthalmic Drugs Product Portfolios and Specifications
Table 136. Guangdong Zhongsheng Pharmaceutical NSAID Ophthalmic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. Guangdong Zhongsheng Pharmaceutical Main Business
Table 138. Guangdong Zhongsheng Pharmaceutical Latest Developments
Table 139. Hangzhou Minsheng Pharmaceutical Basic Information, NSAID Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 140. Hangzhou Minsheng Pharmaceutical NSAID Ophthalmic Drugs Product Portfolios and Specifications
Table 141. Hangzhou Minsheng Pharmaceutical NSAID Ophthalmic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. Hangzhou Minsheng Pharmaceutical Main Business
Table 143. Hangzhou Minsheng Pharmaceutical Latest Developments
Table 144. Cisen Pharmaceutical Basic Information, NSAID Ophthalmic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 145. Cisen Pharmaceutical NSAID Ophthalmic Drugs Product Portfolios and Specifications
Table 146. Cisen Pharmaceutical NSAID Ophthalmic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 147. Cisen Pharmaceutical Main Business
Table 148. Cisen Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of NSAID Ophthalmic Drugs
Figure 2. NSAID Ophthalmic Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global NSAID Ophthalmic Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global NSAID Ophthalmic Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. NSAID Ophthalmic Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. NSAID Ophthalmic Drugs Sales Market Share by Country/Region (2025)
Figure 10. NSAID Ophthalmic Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Pranoprofen Eye Drops
Figure 12. Product Picture of Diclofenac Sodium Eye Drops
Figure 13. Product Picture of Bromfenac Sodium Eye Drops
Figure 14. Product Picture of Other
Figure 15. Global NSAID Ophthalmic Drugs Sales Market Share by Type in 2026
Figure 16. Global NSAID Ophthalmic Drugs Revenue Market Share by Type (2021-2026)
Figure 17. NSAID Ophthalmic Drugs Consumed in Hospital
Figure 18. Global NSAID Ophthalmic Drugs Market: Hospital (2021-2026) & (K Units)
Figure 19. NSAID Ophthalmic Drugs Consumed in Clinic
Figure 20. Global NSAID Ophthalmic Drugs Market: Clinic (2021-2026) & (K Units)
Figure 21. NSAID Ophthalmic Drugs Consumed in Other
Figure 22. Global NSAID Ophthalmic Drugs Market: Other (2021-2026) & (K Units)
Figure 23. Global NSAID Ophthalmic Drugs Sale Market Share by Application (2025)
Figure 24. Global NSAID Ophthalmic Drugs Revenue Market Share by Application in 2026
Figure 25. NSAID Ophthalmic Drugs Sales by Company in 2026 (K Units)
Figure 26. Global NSAID Ophthalmic Drugs Sales Market Share by Company in 2026
Figure 27. NSAID Ophthalmic Drugs Revenue by Company in 2026 ($ millions)
Figure 28. Global NSAID Ophthalmic Drugs Revenue Market Share by Company in 2026
Figure 29. Global NSAID Ophthalmic Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global NSAID Ophthalmic Drugs Revenue Market Share by Geographic Region in 2026
Figure 31. Americas NSAID Ophthalmic Drugs Sales 2021-2026 (K Units)
Figure 32. Americas NSAID Ophthalmic Drugs Revenue 2021-2026 ($ millions)
Figure 33. APAC NSAID Ophthalmic Drugs Sales 2021-2026 (K Units)
Figure 34. APAC NSAID Ophthalmic Drugs Revenue 2021-2026 ($ millions)
Figure 35. Europe NSAID Ophthalmic Drugs Sales 2021-2026 (K Units)
Figure 36. Europe NSAID Ophthalmic Drugs Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa NSAID Ophthalmic Drugs Sales 2021-2026 (K Units)
Figure 38. Middle East & Africa NSAID Ophthalmic Drugs Revenue 2021-2026 ($ millions)
Figure 39. Americas NSAID Ophthalmic Drugs Sales Market Share by Country in 2026
Figure 40. Americas NSAID Ophthalmic Drugs Revenue Market Share by Country (2021-2026)
Figure 41. Americas NSAID Ophthalmic Drugs Sales Market Share by Type (2021-2026)
Figure 42. Americas NSAID Ophthalmic Drugs Sales Market Share by Application (2021-2026)
Figure 43. United States NSAID Ophthalmic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada NSAID Ophthalmic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico NSAID Ophthalmic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil NSAID Ophthalmic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC NSAID Ophthalmic Drugs Sales Market Share by Region in 2026
Figure 48. APAC NSAID Ophthalmic Drugs Revenue Market Share by Region (2021-2026)
Figure 49. APAC NSAID Ophthalmic Drugs Sales Market Share by Type (2021-2026)
Figure 50. APAC NSAID Ophthalmic Drugs Sales Market Share by Application (2021-2026)
Figure 51. China NSAID Ophthalmic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan NSAID Ophthalmic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea NSAID Ophthalmic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia NSAID Ophthalmic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 55. India NSAID Ophthalmic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia NSAID Ophthalmic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan NSAID Ophthalmic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe NSAID Ophthalmic Drugs Sales Market Share by Country in 2026
Figure 59. Europe NSAID Ophthalmic Drugs Revenue Market Share by Country (2021-2026)
Figure 60. Europe NSAID Ophthalmic Drugs Sales Market Share by Type (2021-2026)
Figure 61. Europe NSAID Ophthalmic Drugs Sales Market Share by Application (2021-2026)
Figure 62. Germany NSAID Ophthalmic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 63. France NSAID Ophthalmic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 64. UK NSAID Ophthalmic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy NSAID Ophthalmic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia NSAID Ophthalmic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa NSAID Ophthalmic Drugs Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa NSAID Ophthalmic Drugs Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa NSAID Ophthalmic Drugs Sales Market Share by Application (2021-2026)
Figure 70. Egypt NSAID Ophthalmic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa NSAID Ophthalmic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel NSAID Ophthalmic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey NSAID Ophthalmic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries NSAID Ophthalmic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of NSAID Ophthalmic Drugs in 2026
Figure 76. Manufacturing Process Analysis of NSAID Ophthalmic Drugs
Figure 77. Industry Chain Structure of NSAID Ophthalmic Drugs
Figure 78. Channels of Distribution
Figure 79. Global NSAID Ophthalmic Drugs Sales Market Forecast by Region (2027-2032)
Figure 80. Global NSAID Ophthalmic Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global NSAID Ophthalmic Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global NSAID Ophthalmic Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global NSAID Ophthalmic Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global NSAID Ophthalmic Drugs Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of NSAID Ophthalmic Drugs
Figure 2. NSAID Ophthalmic Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global NSAID Ophthalmic Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global NSAID Ophthalmic Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. NSAID Ophthalmic Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. NSAID Ophthalmic Drugs Sales Market Share by Country/Region (2025)
Figure 10. NSAID Ophthalmic Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Pranoprofen Eye Drops
Figure 12. Product Picture of Diclofenac Sodium Eye Drops
Figure 13. Product Picture of Bromfenac Sodium Eye Drops
Figure 14. Product Picture of Other
Figure 15. Global NSAID Ophthalmic Drugs Sales Market Share by Type in 2026
Figure 16. Global NSAID Ophthalmic Drugs Revenue Market Share by Type (2021-2026)
Figure 17. NSAID Ophthalmic Drugs Consumed in Hospital
Figure 18. Global NSAID Ophthalmic Drugs Market: Hospital (2021-2026) & (K Units)
Figure 19. NSAID Ophthalmic Drugs Consumed in Clinic
Figure 20. Global NSAID Ophthalmic Drugs Market: Clinic (2021-2026) & (K Units)
Figure 21. NSAID Ophthalmic Drugs Consumed in Other
Figure 22. Global NSAID Ophthalmic Drugs Market: Other (2021-2026) & (K Units)
Figure 23. Global NSAID Ophthalmic Drugs Sale Market Share by Application (2025)
Figure 24. Global NSAID Ophthalmic Drugs Revenue Market Share by Application in 2026
Figure 25. NSAID Ophthalmic Drugs Sales by Company in 2026 (K Units)
Figure 26. Global NSAID Ophthalmic Drugs Sales Market Share by Company in 2026
Figure 27. NSAID Ophthalmic Drugs Revenue by Company in 2026 ($ millions)
Figure 28. Global NSAID Ophthalmic Drugs Revenue Market Share by Company in 2026
Figure 29. Global NSAID Ophthalmic Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global NSAID Ophthalmic Drugs Revenue Market Share by Geographic Region in 2026
Figure 31. Americas NSAID Ophthalmic Drugs Sales 2021-2026 (K Units)
Figure 32. Americas NSAID Ophthalmic Drugs Revenue 2021-2026 ($ millions)
Figure 33. APAC NSAID Ophthalmic Drugs Sales 2021-2026 (K Units)
Figure 34. APAC NSAID Ophthalmic Drugs Revenue 2021-2026 ($ millions)
Figure 35. Europe NSAID Ophthalmic Drugs Sales 2021-2026 (K Units)
Figure 36. Europe NSAID Ophthalmic Drugs Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa NSAID Ophthalmic Drugs Sales 2021-2026 (K Units)
Figure 38. Middle East & Africa NSAID Ophthalmic Drugs Revenue 2021-2026 ($ millions)
Figure 39. Americas NSAID Ophthalmic Drugs Sales Market Share by Country in 2026
Figure 40. Americas NSAID Ophthalmic Drugs Revenue Market Share by Country (2021-2026)
Figure 41. Americas NSAID Ophthalmic Drugs Sales Market Share by Type (2021-2026)
Figure 42. Americas NSAID Ophthalmic Drugs Sales Market Share by Application (2021-2026)
Figure 43. United States NSAID Ophthalmic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada NSAID Ophthalmic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico NSAID Ophthalmic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil NSAID Ophthalmic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC NSAID Ophthalmic Drugs Sales Market Share by Region in 2026
Figure 48. APAC NSAID Ophthalmic Drugs Revenue Market Share by Region (2021-2026)
Figure 49. APAC NSAID Ophthalmic Drugs Sales Market Share by Type (2021-2026)
Figure 50. APAC NSAID Ophthalmic Drugs Sales Market Share by Application (2021-2026)
Figure 51. China NSAID Ophthalmic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan NSAID Ophthalmic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea NSAID Ophthalmic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia NSAID Ophthalmic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 55. India NSAID Ophthalmic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia NSAID Ophthalmic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan NSAID Ophthalmic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe NSAID Ophthalmic Drugs Sales Market Share by Country in 2026
Figure 59. Europe NSAID Ophthalmic Drugs Revenue Market Share by Country (2021-2026)
Figure 60. Europe NSAID Ophthalmic Drugs Sales Market Share by Type (2021-2026)
Figure 61. Europe NSAID Ophthalmic Drugs Sales Market Share by Application (2021-2026)
Figure 62. Germany NSAID Ophthalmic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 63. France NSAID Ophthalmic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 64. UK NSAID Ophthalmic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy NSAID Ophthalmic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia NSAID Ophthalmic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa NSAID Ophthalmic Drugs Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa NSAID Ophthalmic Drugs Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa NSAID Ophthalmic Drugs Sales Market Share by Application (2021-2026)
Figure 70. Egypt NSAID Ophthalmic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa NSAID Ophthalmic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel NSAID Ophthalmic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey NSAID Ophthalmic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries NSAID Ophthalmic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of NSAID Ophthalmic Drugs in 2026
Figure 76. Manufacturing Process Analysis of NSAID Ophthalmic Drugs
Figure 77. Industry Chain Structure of NSAID Ophthalmic Drugs
Figure 78. Channels of Distribution
Figure 79. Global NSAID Ophthalmic Drugs Sales Market Forecast by Region (2027-2032)
Figure 80. Global NSAID Ophthalmic Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global NSAID Ophthalmic Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global NSAID Ophthalmic Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global NSAID Ophthalmic Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global NSAID Ophthalmic Drugs Revenue Market Share Forecast by Application (2027-2032)
